XTL Biopharmaceuticals Ltd. (XTLB)
NASDAQ: XTLB · Real-Time Price · USD
2.820
-0.030 (-1.05%)
At close: Jul 31, 2026, 4:00 PM EDT
2.590
-0.230 (-8.16%)
After-hours: Jul 31, 2026, 4:27 PM EDT

XTL Biopharmaceuticals Statistics

Total Valuation

XTLB has a market cap or net worth of $6.41 million. The enterprise value is $6.33 million.

Market Cap6.41M
Enterprise Value 6.33M

Important Dates

The last earnings date was Tuesday, June 30, 2026, after market close.

Earnings Date Jun 30, 2026
Ex-Dividend Date n/a

Share Statistics

XTLB has 982.99 million shares outstanding. The number of shares has increased by 52.32% in one year.

Current Share Class n/a
Shares Outstanding 982.99M
Shares Change (YoY) +52.32%
Shares Change (QoQ) n/a
Owned by Insiders (%) 38.87%
Owned by Institutions (%) 3.01%
Float 600.87M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.40

Current Ratio 0.40
Quick Ratio 0.18
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -241.14

Financial Efficiency

Return on equity (ROE) is -29.30% and return on invested capital (ROIC) is -34.43%.

Return on Equity (ROE) -29.30%
Return on Assets (ROA) -21.01%
Return on Invested Capital (ROIC) -34.43%
Return on Capital Employed (ROCE) 664.57%
Weighted Average Cost of Capital (WACC) 7.28%
Revenue Per Employee n/a
Profits Per Employee -$1.39M
Employee Count5
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -57.01% in the last 52 weeks. The beta is 0.55, so XTLB's price volatility has been lower than the market average.

Beta (5Y) 0.55
52-Week Price Change -57.01%
50-Day Moving Average 2.63
200-Day Moving Average 3.13
Relative Strength Index (RSI) 50.17
Average Volume (20 Days) 15,311

Short Selling Information

The latest short interest is 36,172, so 1.96% of the outstanding shares have been sold short.

Short Interest 36,172
Short Previous Month 9,362
Short % of Shares Out 1.96%
Short % of Float n/a
Short Ratio (days to cover) 0.19

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -1.47M
Pretax Income -759,000
Net Income -6.97M
EBITDA -1.69M
EBIT -1.69M
Earnings Per Share (EPS) -$0.01
Full Income Statement

Balance Sheet

The company has $76,000 in cash and no debt, with a net cash position of $76,000 or $0.00 per share.

Cash & Cash Equivalents 76,000
Total Debt n/a
Net Cash 76,000
Net Cash Per Share $0.00
Equity (Book Value) -254,000
Book Value Per Share -0.00
Working Capital -254,000
Full Balance Sheet

Cash Flow

Operating Cash Flow -1.03M
Capital Expenditures n/a
Depreciation & Amortization 199,000
Net Borrowing 208,000
Free Cash Flow -1.03M
FCF Per Share -$0.00
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

XTLB does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -52.32%
Shareholder Yield -52.32%
Earnings Yield -108.68%
FCF Yield -15.99%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (3Y) n/a
EPS Growth Forecast (3Y) n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on March 25, 2026. It was a reverse split with a ratio of 1:4.

Last Split Date Mar 25, 2026
Split Type Reverse
Split Ratio 1:4

Scores

Altman Z-Score n/a
Piotroski F-Score 1